Is the Success of Adaptive Therapy in Metastatic Castrate Resistant Prostate Cancer Influenced by Cell-Type-Dependent Production of Prostate Specific Antigen?
M. Salvioli, L. Vandelaer, K. Schneider, R. Cavill, K. Stankova
This study evaluates how different cell-type contributions to PSA production affect the success of adaptive therapy in metastatic castrate-resistant prostate cancer.
bioRxiv · Oct 21, 2021 · PreprintCancer Biology